McIlrath & Eck, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 439 filers reported holding REPLIGEN CORP in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
McIlrath & Eck, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$5,565
+12.4%
350.0%0.00%0.0%
Q2 2023$4,951
-16.0%
350.0%0.00%0.0%
Q1 2023$5,893
-0.6%
350.0%0.00%
-50.0%
Q4 2022$5,926
-15.3%
350.0%0.00%0.0%
Q3 2022$7,000
+16.7%
350.0%0.00%0.0%
Q2 2022$6,000
-14.3%
350.0%0.00%0.0%
Q1 2022$7,000
-22.2%
350.0%0.00%0.0%
Q4 2021$9,000
-10.0%
350.0%0.00%
-33.3%
Q3 2021$10,000
+42.9%
350.0%0.00%
+50.0%
Q2 2021$7,0000.0%350.0%0.00%0.0%
Q1 2021$7,000350.00%
Other shareholders
REPLIGEN CORP shareholders Q1 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders